
Proceedings of the WFH’s Eighth Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders
A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia

A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders

A discussion of the mild forms of hemophilia A and hemophilia B, from epidemiology and molecular basis, via diagnosis, to

Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an

This report reviews the spectrum of indications of desmopressin in the treatment of bleeding disorders.

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the